QVT Financial LP 4
4 · Roivant Sciences Ltd. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
QVT Financial LP
Other
Transactions
- Sale
Common Shares
2025-12-16$22.93/sh−275,000$6,305,750→ 17,772,727 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-16$23.08/sh−642,282$14,823,869→ 17,130,445 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-17$23.05/sh−432,718$9,974,150→ 16,697,727 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-17$23.02/sh−155,076$3,569,850→ 16,542,651 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-17$23.17/sh−189,538$4,391,595→ 16,353,113 total(indirect: Held by QVT Financial Investment Cayman Ltd.)
Footnotes (2)
- [F1]Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 26,387,021 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC, a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.
- [F2]QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.